CLDX
Price
$41.97
Change
+$0.18 (+0.43%)
Updated
Mar 28, 6:59 PM EST
35 days until earnings call
REPL
Price
$8.17
Change
-$0.08 (-0.97%)
Updated
Mar 28, 6:59 PM EST
48 days until earnings call
Ad is loading...

CLDX vs REPL ᐉ Comparison: Which is Better to Invest?

Header iconCLDX vs REPL Comparison
Open Charts CLDX vs REPLBanner chart's image
Celldex Therapeutics
Price$41.97
Change+$0.18 (+0.43%)
Volume$374.27K
CapitalizationN/A
Replimune Group
Price$8.17
Change-$0.08 (-0.97%)
Volume$701.9K
CapitalizationN/A
View a ticker or compare two or three
CLDX vs REPL Comparison Chart

Loading...

CLDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
REPLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CLDX vs. REPL commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and REPL is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (CLDX: $41.89 vs. REPL: $8.15)
Brand notoriety: CLDX and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 33% vs. REPL: 74%
Market capitalization -- CLDX: $2.75B vs. REPL: $500.31M
CLDX [@Biotechnology] is valued at $2.75B. REPL’s [@Biotechnology] market capitalization is $500.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 1 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 1 green, 4 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, CLDX is a better buy in the long-term than REPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 6 TA indicator(s) are bullish while REPL’s TA Score has 5 bullish TA indicator(s).

  • CLDX’s TA Score: 6 bullish, 4 bearish.
  • REPL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both CLDX and REPL are a good buy in the short-term.

Price Growth

CLDX (@Biotechnology) experienced а +2.15% price change this week, while REPL (@Biotechnology) price change was -0.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

CLDX is expected to report earnings on May 02, 2024.

REPL is expected to report earnings on May 16, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CLDX with price predictions.
OPEN
A.I.dvisor published
a Summary for REPL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CLDX($2.75B) has a higher market cap than REPL($500M). CLDX YTD gains are higher at: 5.825 vs. REPL (-3.321). CLDX has higher annual earnings (EBITDA): -139.03M vs. REPL (-200.44M). REPL has more cash in the bank: 466M vs. CLDX (424M). CLDX has less debt than REPL: CLDX (2.54M) vs REPL (75.8M). CLDX has higher revenues than REPL: CLDX (6.88M) vs REPL (0).
CLDXREPLCLDX / REPL
Capitalization2.75B500M550%
EBITDA-139.03M-200.44M69%
Gain YTD5.825-3.321-175%
P/E RatioN/AN/A-
Revenue6.88M0-
Total Cash424M466M91%
Total Debt2.54M75.8M3%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXREPL
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CLDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
REPLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVVX37.270.15
+0.40%
JHancock Classic Value R5
LCFLX12.380.03
+0.24%
Lord Abbett Focused Large Cap Value C
ASRFX8.160.01
+0.16%
Invesco Global Real Estate Income R6
REQAX47.040.07
+0.15%
Russell Inv Sustainable Equity A
WEUSX12.210.01
+0.08%
SEI World Equity Ex-US A (SIIT)